First author of the article - Raphael Escaig/LinkedIn
Apr 21, 2026, 11:34
Are Platelets Really Just Clotting Cells or Immune Orchestrators? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Raphael Escaig et al, adding:
”Are platelets really just clotting cells or immune orchestrators?
We’ve long viewed platelets through a hemostasis lens.
But emerging data are reshaping that paradigm.
A new State-of-the-Art review in RPTH breaks this wide open.
Here’s the key signal:
- Platelets actively coordinate innate and adaptive immunity
- Distinct effector programs (procoagulant, secretory, immune-interacting) operate in parallel
- These functions are context-dependent, protective vs pathogenic
What’s changing under the hood:
- Platelets migrate (Arp2/3-driven haptotaxis) to sites of injury and infection
- Procoagulant platelets localize coagulation to microlesions (not just thrombi)
- Platelet–neutrophil interactions drive NETosis and thromboinflammation
- Platelet aging shifts function from hemostatic to immune
Conceptual insight:
- Platelets are not ‘activated vs resting’
- They operate as modular effector systems tuned by the microenvironment
Big questions for the field:
- What dictates which platelet program dominates in disease?
- Can we selectively block thromboinflammation without impairing vascular protection?
- How does platelet programming (e.g., megakaryocyte origin, cargo) shape outcomes?
- Platelet biology is evolving, and it’s becoming clear that thrombosis, inflammation, and immunity are deeply intertwined.”
Title: Platelet effector functions in inflammation
Authors: Raphael Escaig, Lennart Kreutz, Rainer Kaiser, Leo Nicolai
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 13, 2026, 05:36Speaking Up When Women’s Health Concerns Are Dismissed – Haemophilia Foundation Australia
-
Sep 13, 2026, 05:16W. Alberto Sifuentes Giraldo: Dual Targeted Therapy Shows Promise in Refractory Systemic Autoinflammatory Diseases
-
Sep 13, 2026, 04:42Christopher Robinson: Early Pregnancy Oxylipins May Signal Risk of Fetal Growth Restriction
-
Sep 13, 2026, 04:22Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
-
Sep 13, 2026, 03:40Mizinga Moonze: When Blood Speaks – The Missing Link in Healthcare Sustainability
-
Sep 12, 2026, 17:55Dries De Wolf: Honored to Have Wolfgang Miesbach Comment on Our Latest Research
-
Sep 12, 2026, 17:53Usman Waheed: Introducing the Discovery of the 49th ISBT Blood Group System
-
Sep 12, 2026, 17:51Maria Sabater Lleal: Happy to Share Our Latest Work Exploring the Genetic Determinants of PE in VTE
-
Sep 12, 2026, 17:51Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?